Article
Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma.
Journal of human genetics - 1 Jan 2007
Imanishi Hiroyuki, Okamura Noboru, Yagi Mariko, Noro Yukari, Moriya Yuka, Nakamura Tsutomu, Hayakawa Akira, Takeshima Yasuhiro, Sakaeda Toshiyuki, Matsuo Masafumi, Okumura Katsuhiko
Abstract excerpt
Methotrexate is administered in high doses to treat childhood acute lymphoblastic leukemia and malignant lymphoma. Hepatotoxicity and bone marrow suppression often limit its use, however. The objective of this study was to determine the genetic polymorphisms associated with the hepatotoxicity and elimination of methotrexate. Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
